Seattle, WA, United States of America

Karl-Erik Hellstrom

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fujirebio Diagnostics, Inc., Pacific Northwest Diabetes Research Institute. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karl-Erik Hellstrom

Introduction

Karl-Erik Hellstrom is a notable inventor based in Seattle, WA. He has made significant contributions to the field of medical diagnostics, particularly in relation to ovarian cancer. His work has the potential to improve the lives of many patients through innovative methods of assessment and treatment.

Latest Patents

Karl-Erik Hellstrom holds a patent for "Compositions and methods of use for determination of HE4a." This invention utilizes HE/HE4a markers to assess ovarian cancer in subjects. It includes compositions and methods for diagnosing, grading, and staging ovarian cancers, as well as determining prognosis and treatment effectiveness for diagnosed patients. He has 1 patent to his name.

Career Highlights

Throughout his career, Hellstrom has worked with reputable organizations, including the Pacific Northwest Diabetes Research Institute and Fujirebio Diagnostics, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical diagnostics.

Collaborations

Some of his notable coworkers include Ingegerd E Hellstrom and John Raycraft. Their collaborative efforts have contributed to advancements in the field of cancer diagnostics.

Conclusion

Karl-Erik Hellstrom's work exemplifies the impact of innovation in medical science. His contributions to ovarian cancer diagnostics highlight the importance of research and development in improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…